Cancer remains one of the leading causes of death around the world, but advancements in genomics are enhancing detection and screening capabilities. For investors, that puts the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) at the forefront of vital healthcare developments. Advancements in...